Holdings
Rtw Investments, LP
As of Sep 30, 2026, Rtw Investments, LP reported 78 positions worth US$9.36B. Largest: Protagonist Therapeutics, Inc., argenx SE and CG Oncology, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 5.06M | US$713M | no change | Sep 30, 2026 |
| argenx SE | 712K | US$682M | +2,138 | Sep 30, 2026 |
| CG Oncology, Inc. | 8.51M | US$604M | no change | Sep 30, 2026 |
| iRhythm Holdings, Inc. | 3.12M | US$354M | +936K | Sep 30, 2026 |
| Insmed Incorporated | 3.1M | US$353M | −1.75M | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 14M | US$351M | +148K | Sep 30, 2026 |
| Erasca, Inc. | 22.4M | US$329M | +4.5M | Sep 30, 2026 |
| Spyre Therapeutics, Inc. | 3.69M | US$329M | −560K | Sep 30, 2026 |
| RadNet, Inc. | 4.63M | US$319M | −216K | Sep 30, 2026 |
| Tarsus Pharmaceuticals, Inc. | 3.48M | US$274M | +127K | Sep 30, 2026 |